These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32536282)

  • 21. Biology and treatment of acute promyelocytic leukemia.
    Fenaux P; Chomienne C
    Curr Opin Oncol; 1996 Jan; 8(1):3-12. PubMed ID: 8868093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chinese guidelines for the diagnosis and treatment of acute promyelocytic leukemia].
    Shen ZX;
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):885-6. PubMed ID: 22339972
    [No Abstract]   [Full Text] [Related]  

  • 23. Addressing the room for improvement in management of acute promyelocytic leukemia.
    Nørgaard JM; Friis LS; Kristensen JS; Severinsen MT; Mølle I; Marcher CW; Møller P; Schoellkopf C; Nielsen OJ; Preiss BS; Andersen MK; Kjeldsen E; Medeiros BC; Østgård LSG;
    Eur J Haematol; 2019 Jun; 102(6):479-485. PubMed ID: 30887583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy.
    Gurnari C; Voso MT; Girardi K; Mastronuzzi A; Strocchio L
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Interpretation of the expert Chinese guideline for diagnosis and treatment of acute promyelocytic leukemia (2014)].
    Shen Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 May; 35(5):478. PubMed ID: 24857228
    [No Abstract]   [Full Text] [Related]  

  • 26. Spanish contributions to management of acute promyelocytic leukemia.
    Haematologica; 2001 Jun; 86(6):561-2. PubMed ID: 11418363
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment advances have not improved the early death rate in acute promyelocytic leukemia.
    McClellan JS; Kohrt HE; Coutre S; Gotlib JR; Majeti R; Alizadeh AA; Medeiros BC
    Haematologica; 2012 Jan; 97(1):133-6. PubMed ID: 21993679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute promyelocytic leukemia: progress far and wide.
    Powell BL
    Blood; 2013 Mar; 121(11):1925-6. PubMed ID: 23493766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy of acute promyelocytic leukemia.
    Soignet S; Maslak P
    Adv Pharmacol; 2004; 51():35-58. PubMed ID: 15464904
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of acute promyelocytic leukemia for older patients.
    Prebet T; Gore SD
    J Natl Compr Canc Netw; 2011 Mar; 9(3):337-42. PubMed ID: 21393443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-2. Acute promyelocytic leukemia (APL).
    Fujita H; Ishikawa Y; Yokoyama Y
    Int J Hematol; 2020 Jun; 111(6):747-760. PubMed ID: 32347422
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience.
    Pulsoni A; Pagano L; Lo Coco F; Avvisati G; Mele L; Di Bona E; Invernizzi R; Leoni F; Marmont F; Mele A; Melillo L; Nosari AM; Pogliani EM; Vignetti M; Visani G; Zagonel V; Leone G; Mandelli F
    Blood; 2002 Sep; 100(6):1972-6. PubMed ID: 12200354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Microgranular-type acute promyelocytic leukemia with weak myeloperoxidase staining: difficulty of morphological diagnosis].
    Matsuda H; Misawa K; Ochiai T; Fujioka I; Iwasaki H; Iwao N; Koike M; Komatsu N
    Rinsho Ketsueki; 2020; 61(10):1511-1513. PubMed ID: 33162450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of acute promyelocytic leukemia.
    Arlin ZA
    Blood; 1992 Sep; 80(5):1365-6. PubMed ID: 1472246
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality of life with treated acute promyelocytic leukaemia.
    Rahman A
    Lancet Oncol; 2014 Nov; 15(12):e533. PubMed ID: 25602107
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute promyelocytic leukemia: recent advances in diagnosis and management.
    Lo-Coco F; Ammatuna E; Montesinos P; Sanz MA
    Semin Oncol; 2008 Aug; 35(4):401-9. PubMed ID: 18692690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving Outcomes of Acute Promyelocytic Leukemia in the Current Era: Analysis of the SEER Database.
    Guru Murthy GS; Szabo A; Michaelis L; Carlson KS; Runaas L; Abedin S; Atallah E
    J Natl Compr Canc Netw; 2020 Feb; 18(2):169-175. PubMed ID: 32023530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-risk acute promyelocytic leukemia with early differentiation syndrome: a therapeutic dilemma.
    Malato A; Santoro A; Felice R; Magrin S; Turri D; Bica MG; Salemi D; Fabbiano F
    Acta Haematol; 2012; 127(1):60-2. PubMed ID: 22094378
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coexistence of Acute Promyelocytic Leukemia and Primary Plasma Cell Leukemia: Careful Consideration in Diagnosis.
    Park JH; Choi HW; Shin MG
    Ann Lab Med; 2022 Mar; 42(2):278-281. PubMed ID: 34635620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.